hotspot -WSS

hotspot

author：fashion 2025-09-29 21:28:26 - browse：483

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： How neuroscience research could help beat back brain cancer

knowledge

WSS

An Ebola outbreak presents a new mystery involving children

Explaining an after

In venture capital firm's success, lessons for turning crisis into profit

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

All of Us, NIH's precision medicine initiative, gets a big boost

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

focus

hotspot

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Key Senate panel to consider PBM, drug pricing reform package

Jerome Adams on the need for new antivirals for Covid

Inari Medical to buy amputation prevention company LimFlow

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Travis Kelce and the trap of celebrity vaccine endorsements

Psychedelics group wrestles with new pharma identity

More regulation could be coming for drug ads

New air purifier tech could be key to improving indoor air quality

Brain injuries and the importance of a second opinion

hotspot

Gene therapy’s promise and the high cost of hope

Sage's campaign to raise awareness of postpartum depression hits a nerve

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

How neuroscience research could help beat back brain cancer

Choosing scientific sides in the fight against Alzheimer's

Choosing scientific sides in the fight against Alzheimer's

knowledge

knowledge

knowledge

leisure time